Related Experiment Video

Updated: Jun 20, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Bronchopulmonary dysplasia

Kathleen M Deakins1

  • 1Pediatric Respiratory Care, Rainbow Babies and Children's Hospital, 11100 Euclid Avenue, Cleveland OH 44106, USA. kathleen.deakins@uhhospitals.org

Respiratory Care
|August 29, 2009
PubMed

Insights

Bronchopulmonary dysplasia (BPD) is a chronic lung disease in infants, often linked to prematurity. Prevention strategies focus on minimizing lung injury and long-term complications.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Respiratory Medicine

Background:

  • Bronchopulmonary dysplasia (BPD) is the most frequent chronic respiratory disease in infants, stemming from lung injury during respiratory distress syndrome treatment or abnormal lung development.
  • The incidence of BPD is increasing due to improved survival rates of low-birth-weight infants.
  • Evolving definitions and classifications reflect changes in BPD diagnosis over time.

Purpose of the Study:

  • To review and summarize current prevention strategies for bronchopulmonary dysplasia (BPD) in premature infants.
  • To highlight the importance of minimizing lung injury and long-term sequelae associated with BPD treatment.
  • To discuss various therapeutic interventions aimed at reducing the incidence and impact of BPD.

Main Methods:

  • Review of existing literature on BPD prevention and management.
  • Analysis of therapeutic interventions including surfactant replacement, ventilation strategies, and pharmacotherapy.
  • Examination of changes in delivery room practices and postnatal care.

Main Results:

  • Multiple interventions show promise in BPD prevention, including surfactant therapy, optimized ventilation, and judicious oxygen management.
  • Pharmacological agents like caffeine and inhaled nitric oxide are key in managing BPD development.
  • Nutritional support and specific ventilator strategies are crucial for mitigating long-term effects.

Conclusions:

  • Preventing BPD is paramount, focusing on minimizing initial lung injury and subsequent complications.
  • A multifaceted approach combining respiratory support, pharmacological treatments, and careful postnatal care is essential for BPD management.
  • Continued research into novel prevention and treatment strategies is vital given the rising incidence of BPD.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.